Fulcrum Equity Management Bio Techne Corp Transaction History

Fulcrum Equity Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 15, 2022	SELL	$353.85 - $487.79 $810,316 - $1.12 Million	-2,290 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$456.15 - $525.06 $253,163 - $291,408	-555 Reduced 19.51%	2,290 $1.19 Million
Q3 2021 Jan 25, 2022	SELL	$444.87 - $538.88 $638,833 - $773,831	-1,436 Reduced 33.54%	2,845 $1.38 Million
Q2 2021 Jul 15, 2021	SELL	$387.35 - $450.26 $492,321 - $572,280	-1,271 Reduced 22.89%	4,281 $1.93 Million
Q1 2021 Apr 05, 2021	BUY	$314.62 - $411.0 $1.75 Million - $2.28 Million	5,552 New	5,552 $2.12 Million

598

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Equity Management with notifications on news.